Envestnet Asset Management
ROIV icon

Envestnet Asset Management’s Roivant Sciences ROIV Stock Holding History

Envestnet Asset Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.3M Buy
713,946
+35,428
+5% +$1.05M 0.01% 1278
2026
Q1 		$18.8M Buy
678,518
+37,057
+6% +$952K 0.01% 1381
2025
Q4 		$13.9M Buy
641,461
+603,172
+1,575% +$11.9M ﹤0.01% 1473
2025
Q3 		$579K Sell
38,289
-4,521
-11% -$56K ﹤0.01% 3654
2025
Q2 		$482K Buy
42,810
+9,936
+30% +$108K ﹤0.01% 3713
2025
Q1 		$332K Buy
32,874
+5,953
+22% +$64.4K ﹤0.01% 3871
2024
Q4 		$318K Buy
+26,921
New +$318K ﹤0.01% 3869

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Envestnet Asset Management's ROIV Position: Q2 2026 in Review

Envestnet Asset Management increased its Roivant Sciences (ROIV) stake by 5.2% in Q2 2026, buying an estimated $1.05M and bringing the position to 713,946 shares worth $25.3M. The position accounts for 0.01% of the portfolio, ranked #1278.

Envestnet Asset Management first reported a position in ROIV in Q4 2024 and has held it in 7 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Envestnet Asset Management held 713,946 shares of Roivant Sciences worth $25.3M as of Q2 2026.
  • Envestnet Asset Management bought 35,428 Roivant Sciences shares in Q2 2026, an estimated $1.05M.
  • Roivant Sciences made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1278 holding.
  • Envestnet Asset Management first reported a position in Roivant Sciences in Q4 2024 and has held it in 7 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.